Skip to main content
Pharmocann Global Ltd. logo

Pharmocann Global Ltd. — Investor Relations & Filings

Ticker · PMCN-M ISIN · IL0010968902 TA Manufacturing
Open in API
Filings indexed 5 across all filing types
Latest filing 2025-08-04 Regulatory Filings
Country IL Israel
Listing TA PMCN-M

About Pharmocann Global Ltd.

https://www.pharmocann.co.il

Pharmocann Global Ltd. is a company specializing in the research, cultivation, production, and distribution of medical-grade cannabis products. Its product portfolio includes various formulations such as oils, ointments, tablets, and inhalers designed for medical applications. The company emphasizes a pharmaceutical approach, adhering to Good Manufacturing Practices (GMP) to create standardized and validated cannabis-based medicines. It operates its own cultivation facilities, including research and development greenhouses, and collaborates with research institutions to advance its product development. The company also produces and distributes hemp-based cosmetic and seed oil products.

Recent filings

Filing Released Lang Actions
The sector classification of BLUE WAVE WATER CAPITAL will be changed, as of August 6, 2025 from –BIOMED – Subsector CANNABIS, to Sector TECHNOLOGY – Subsector CLEANTECH
Regulatory Filings Classification · 100% confidence The document is a short notification from the Tel Aviv Stock Exchange (TASE) regarding a change in the company's sector classification. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As it is a general regulatory notice regarding company status, it falls under the RNS (Regulatory Filings) category.
2025-08-04 English
Changes in the company's name and security, effective as of February 19, 2025
Regulatory Filings Classification · 95% confidence The document is a brief announcement from the Listing Companies Compliance Unit to TASE members regarding a change in the company's name and corresponding changes in security name and symbol. It does not contain financial data, management discussion, voting results, or detailed report content. The document is short (722 characters) and serves as a regulatory update about the company's listing information. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-02-17 Hebrew (modern)
Excellence will cease to operate as a market maker in the company's shares as of October 24 ,2023
Regulatory Filings Classification · 95% confidence The document is a short notification about the discontinuation of market making for a specific security (PHARMOCANN-M) by a particular investment management firm. It does not contain financial statements, management discussion, or any detailed report content. It is an official announcement related to trading activity rather than a financial report or regulatory filing about company operations or governance. The document length is very short (517 characters), and it is clearly an announcement of a market activity change. This fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-10-03 Hebrew (modern)
Investors Presentation - August 2020
Investor Presentation Classification · 99% confidence The document is explicitly titled 'Pharmocann Investors Presentation' and dated August 2020. It contains sections typical of investor materials, such as 'Forward Looking Statement', 'Mission & Vision', 'Our Team', 'Pharmocann In Numbers', 'Our Portfolio', and 'Partner With Us Unique Business Opportunity'. This content structure strongly indicates a presentation designed to inform current and potential investors about the company's strategy, operations, and products. This aligns perfectly with the definition of an Investor Presentation (IP). The document length (16080 chars) is substantial, confirming it is the presentation itself, not just an announcement of one.
2020-08-23 English
Investors Presentation - August 2020
Report Publication Announcement Classification · 98% confidence The document text is very short (2402 characters) and contains metadata typical of a regulatory filing announcement, including dates (23/08/2020), company name (PHARMOCANN GLOBAL LTD), and references to an attached file ('����� ���� *����_�������_isa.pdf*'). Crucially, it includes a section titled '**���� ������� ������� ����� ��� ������:**' (which translates roughly to 'Details of the attached report') and explicitly mentions a link to download a file. This structure strongly suggests the document is an announcement about the publication of a report, rather than the full report itself. Given the context of regulatory filings and the short length, the most appropriate classification is Report Publication Announcement (RPA).
2020-08-23 Russian

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.